Corteva, Inc.
Rank #360ValueCTVA · NYSE · Basic Materials
Corteva, Inc. (CTVA) — Rank #360 by gross profitability (GP/assets 0.20) · ROE 4.3% · Piotroski F-Score 6 / 9.
As-of 2026-09-15 · CIK 0001755672 · all metrics point-in-time as of the filing date.
About
Corteva, Inc. operates in the agriculture business.
Show moreShow less
The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa.
The company was founded in 1802 and is headquartered in Indianapolis, Indiana.
- Industry
- Agricultural Inputs
- Sector
- Basic Materials
- State
- DE
- Filer Category
- Large accelerated filer
- Fiscal Year End
- December 31
- Website
- corteva.com
Financials
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-12-31filed 2026-02-12 | 2024-12-31filed 2025-02-14 | 2023-12-31filed 2024-02-08 | 2022-12-31filed 2023-02-09 |
|---|---|---|---|---|
| Revenue | 17,401.0 | 16,908.0 | 17,226.0 | 17,455.0 |
| Revenue growth (YoY) | 2.9% | -1.8% | -1.3% | 11.5% |
| Cost of revenue | 9,172.0 | 9,529.0 | 9,920.0 | 10,436.0 |
| Gross profit | 8,229.0 | 7,379.0 | 7,306.0 | 7,019.0 |
| Gross margin | 47.3% | 43.6% | 42.4% | 40.2% |
| Selling, general & administrative | 3,492.0 | 3,196.0 | 3,176.0 | 3,173.0 |
| Research & development | 1,474.0 | 1,402.0 | 1,337.0 | 1,216.0 |
| Pre-tax income | 1,688.0 | 1,275.0 | 1,093.0 | 1,426.0 |
| Income tax expense | 484.0 | 412.0 | 152.0 | 210.0 |
| Net income | 1,094.0 | 907.0 | 735.0 | 1,147.0 |
| Net margin | 6.3% | 5.4% | 4.3% | 6.6% |
| EPS (basic) | $1.60 | $1.31 | $1.04 | $1.59 |
| EPS (diluted) | $1.60 | $1.30 | $1.03 | $1.58 |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?